An Analysis of Pharmaceutical Inventory Management at a Leading Teaching and Referral Hospital in Kenya

preprint OA: closed CC-BY-4.0

Abstract

BACKGROUND: Proper pharmaceutical inventory management is critical in guiding decisions that mitigate cyclic stockouts. It sets purchasing priorities, informs the procurement of cost-effective drugs, and ensures that there is a balance between inventory expenditure and the demand for medications. This study aimed to evaluate the drug consumption and expenditure patterns at a leading referral hospital in Western Kenya, i.e., the Jaramogi Oginga Odinga Teaching and Referral Hospital (JOOTRH). Drug consumption and expenditure data at JOOTRH were analyzed over 3 years (2018-2020) using Therapeutic Class (TC), Always Better Control (ABC), and Vital Essential and Non-essential (VEN) analysis. Data sources included the Kenya Health Information System (KHIS), bin cards, invoices, delivery notes, and patient files. RESULTS: The total pharmaceutical expenditure (TPE) over the study period was $1,329,213.91. The annual pharmaceutical expenditure (APE) was $389,158.51, $501,365.79, and $438,689.61 for 2018, 2019, and 2020, respectively. ABC analysis indicated that 53 (18.9%), 56 (19.9%), and 56 (19.9%) of items were Class A medicines in 2018, 2019, and 2020, respectively, and consumed 70.2%, 71.7%, and 72.7% of the APE in 2018, 2019, and 2020, respectively. VEN analysis revealed that 173 drugs were classified as vital items in each of the years 2018, 2019, and 2020, and consumed 77.7%, 75.1%, and 74.2% of the APE in 2018, 2019, and 2020, respectively. TC analysis indicated that anti-infectives were the most consumed class of medicine over the study period and consumed 27.4%, 23.5%, and 30.4% of the APE in 2018, 2019, and 2020, respectively. CONCLUSIONS: According to this analysis, Category I pharmaceuticals accounted for the majority of the total pharmaceutical expenditure at the hospital and require special attention for control.
Full text 621 characters · extracted from oa-doi-fallback · click to expand
There is a newer version available for this {{ publicationType }}. View latest version {{ publication.field_name }} {{ publication.subfield_name }} Copyright: © {{ publicationYear }} {{ publication.presentation_authors[0].full_name + (publication.presentation_authors.length > 1 ? ' et al' : '') }}. This is an open access publication distributed under the terms of the CC BY 4.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Check the {{ publicationType | capitalize }} Source for copyright and license information. Listen on

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-05-19T01:45:01.086888+00:00
unpaywall
last seen: 2026-05-24T02:00:01.246996+00:00
License: CC-BY-4.0